Johnson & Johnson (JNJ)
-NYSE 86.82 
0.39(0.45%) May 24, 4:01PM EDT|After Hours
:
86.75 0.07 (0.08%) May 24, 4:54PM EDT
| Prev Close: | 87.21 |
|---|
| Open: | 86.77 |
|---|
| Bid: | 86.64 x 300 |
|---|
| Ask: | 86.99 x 200 |
|---|
| 1y Target Est: | 86.78 |
|---|
| Beta: | 0.48 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 86.49 - 87.03 |
|---|
| 52wk Range: | 61.71 - 89.99 |
|---|
| Volume: | 10,390,046 |
|---|
| Avg Vol (3m): | 9,887,790 |
|---|
| Market Cap: | 243.87B |
|---|
| P/E (ttm): | 23.58 |
|---|
| EPS (ttm): | 3.68 |
|---|
| Div & Yield: | 2.64 (3.00%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Pfizer’s Setback and 5 Top Stories Affecting Dow Healthcare Stocks This Weekat Wall St. Cheat Sheet(Sat 2:19PM EDT)
- The Top 3 Causes of Diabetesat Motley Fool(Sat 2:15PM EDT)
- Are All-Time Highs Supported In Procter & Gamble?at Wall St. Cheat Sheet(Sat 10:58AM EDT)
- Final Glance: Medical Devices companiesAP(Fri, May 24)
- Final Glance: Pharmaceuticals companiesAP(Fri, May 24)
- Rivaroxaban Gains Approval In Europe For ACS Indicationat Forbes(Fri, May 24)
- [video] Summer Investing: Advice From the Prosat CNBC(Fri, May 24)
- Is Blue-Chip Dividend Investing Only For Rich People?at Seeking Alpha(Fri, May 24)
- Analysts: Johnson & Johnson Drug Revenue Could Double and 3 More Research Notes to Readat Wall St. Cheat Sheet(Fri, May 24)
- Midday Glance: Medical Devices companiesAP(Fri, May 24)
- Midday Glance: Pharmaceuticals companiesAP(Fri, May 24)
- Dow Today: Johnson & Johnson (JNJ) Lowerat TheStreet(Fri, May 24)
- Early Glance: Pharmaceuticals companiesAP(Fri, May 24)
- Early Glance: Medical Devices companiesAP(Fri, May 24)
- Bernanke’s Testimony and Market Uncertainty: Week in Reviewat Wall St. Cheat Sheet(Fri, May 24)
Key Statistics
| Forward P/E (1 yr): | 14.99 |
|---|
| P/S (ttm): | 3.57 |
|---|
| Ex-Dividend Date: | 23-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.39 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.55 |
|---|
Business Summary
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide.
View More